Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00815321
What this trial is testing

Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy

Who this might be right for
Chronic Myeloid Leukemia
Singapore General Hospital 11
Post-approval studies (Phase 4)Study completedNCT02277587
What this trial is testing

Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)

Who this might be right for
Primary Adrenal InsufficiencySecondary Adrenal Insufficiency
University of Roma La Sapienza 89
Early research (Phase 1)Temporarily pausedNCT00909558
What this trial is testing

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Envita Medical Center, Inc. 24
Not applicableNot Yet RecruitingNCT06684899
What this trial is testing

Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients

Who this might be right for
GlioblastomaCytokine-Induced Killer Cells
IRCCS San Raffaele 40
Large-scale testing (Phase 3)UnknownNCT03592706
What this trial is testing

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Who this might be right for
HepatoCellular CarcinomaLiver Cancer
Ivy Life Sciences, Co., Ltd 60
Testing effectiveness (Phase 2)Ended earlyNCT02259348
What this trial is testing

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 12
Early research (Phase 1)UnknownNCT04634370
What this trial is testing

Fase I Clinical Trial on NK Cells for COVID-19

Who this might be right for
Covid19Sars-cov 2
Hospital de Clinicas de Porto Alegre 24
Testing effectiveness (Phase 2)Study completedNCT01105650
What this trial is testing

Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
Masonic Cancer Center, University of Minnesota 13
Early research (Phase 1)Study completedNCT01787474
What this trial is testing

Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT01240005
What this trial is testing

Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Qingdao University 30
Early research (Phase 1)Looking for participantsNCT04254419
What this trial is testing

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

Who this might be right for
High Grade Glioma
Nationwide Children's Hospital 18
Early research (Phase 1)Study completedNCT01875601
What this trial is testing

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Who this might be right for
Solid TumorsBrain TumorsSarcoma+2 more
National Cancer Institute (NCI) 16
Early research (Phase 1)WithdrawnNCT06377228
What this trial is testing

TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

Who this might be right for
Refractory Lupus NephritisRefractory Systemic Sclerosis
Takeda
Testing effectiveness (Phase 2)Looking for participantsNCT07380984
What this trial is testing

PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Ruijin Hospital 47
Early research (Phase 1)Study completedNCT01588769
What this trial is testing

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma Multiforme
CytoVac A/S 23
Testing effectiveness (Phase 2)UnknownNCT02215837
What this trial is testing

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

Who this might be right for
Gastric CancerNeoplasmsGastrointestinal Neoplasms+2 more
Shenzhen Hornetcorn Bio-technology Company, LTD 40
Not applicableStudy completedNCT02733458
What this trial is testing

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal Type
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 52
Testing effectiveness (Phase 2)WithdrawnNCT02118311
What this trial is testing

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Study completedNCT02271711
What this trial is testing

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
M.D. Anderson Cancer Center 12
Early research (Phase 1)Looking for participantsNCT06674265
What this trial is testing

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children
Marzieh Ebrahimi 10
Next Page